Login

Elis, Rings European Trading Day in Paris | Xavier Martiré - Chairman of the Management Board and Chief Executive Officer of Elis SA 00:10:00

Share On Facebook Share On Twitter

Xavier Martire is Chairman-Mgmt Board/CEO at Elis SA.

Recent Videos

00:17:08
Urasar is 100% Hayasa Metals Inc. owned; our exploration license over the Urasar mineral district
00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold 1
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio

Suggestions

00:10:00
ESG Reflections & Future Outlook | Susan H. Mac Cormac - Partner of morrison foerster
00:10:00
Supports founders with early-stage and seed VC funding, investing in their professional & personal growth|Russ Wilcox,Partner,Pillar VC
00:10:00
Base Resources: Scaling Up Mineral Sands Operations in Africa and Madagascar at One-to-One Mining Conference
00:10:00
Advising Across Generations: Brooklyn Brock on Supporting Diverse Clients | Brooklyn Brock, Founder, Ellevate Advisors LLC.
00:10:00
Transforming Organizational Development: HoganTaylor & Regional Food Bank of Oklahoma
00:10:00
Avoiding Financial Frenemies: Six Investing Mistakes You Can't Afford to Make
00:10:00
GoldSource Mines: Advancing the High-Return Eagle Mountain Gold Project in Guyana
00:10:00
W.P. Carey’s €120 Million Deal for Bank Pekao Headquarters in Warsaw
00:10:00
"On Perfect Corp.'s first day on the NYSE, Founder & CEO Alice Chang shares insights on this significant milestone and the company's future."|Alice Chang, CEO of Perfect Corp.
00:10:00
Decades of Market Wisdom: Tangu Tan's Insights on Malaysia's Economic Landscape | Tan Teng Boo, CEO ,  Capital Dynamics.
00:10:00
Appia Rare Earths and Uranium Corp: Exploring High-Grade Critical Minerals in Canada
00:10:00
Canadian Solar CEO Dr. Shawn Qu talks about his own history | Xiaohua Qu Ph.D., CEO, Canadian Solar IncCSIQ:NSQ

© 2026 Nehu